gemzar

If I think about the upside case of taxotere and gemzar over the next 12 to 18 months, where do we see that play out?

Hospira, Inc CEO Discusses Q3 2010 - Earnings Call Transcript -- Seeking Alpha 2010

Just roll in for a second on Greg's questions, can you just more specifically tell us about your capacity on propofol, gemzar and taxotere?

Hospira, Inc CEO Discusses Q3 2010 - Earnings Call Transcript -- Seeking Alpha 2010

If we (inaudible 0:36:07) understand the mix dynamics, obviously the Symbiq dynamic won't change until sometime next year, but certainly, if you think about taxotere and gemzar, you know being relatively larger than those in terms of gross margin, certainly gross margin contribution, are there other mix drivers as we get over the next 12 months, than just laying out those basic ones?

Hospira, Inc CEO Discusses Q3 2010 - Earnings Call Transcript -- Seeking Alpha 2010

If you were to see taxotere and gemzar go better than expected, or hit your upside case, should we expect to see the company reinvest some of that profit in terms of accelerating fall and biologic programs, or other R & D programs, or just without going into specific guidance for 2011, just how are you evaluating those upside cases and what you potentially would do with that cash flow?

Hospira, Inc CEO Discusses Q3 2010 - Earnings Call Transcript -- Seeking Alpha 2010